Cardiovascular outcomes of type 2 myocardial infarction among COVID-19 patients: a propensity matched national study

References

• Sandoval Y, Jaffe AS. Type 2 Myocardial Infarction: jACC review topic of the week. J Am Coll Cardiol. 2019;73(14):1846–1860.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Glob Heart. 2018;13(4):305–338. DOI:10.1016/j.gheart.2018.08.004
   PubMed Web of Science ®Google Scholar
• Furie N, Israel A, Gilad L, et al. Type 2 myocardial infarction in general medical wards: clinical features, treatment, and prognosis in comparison with type 1 myocardial infarction. Medicine (Baltimore). 2019;98(41):e17404. DOI:10.1097/MD.0000000000017404
   PubMed Web of Science ®Google Scholar
• De Michieli L, Babuin L, Vigolo S, et al. Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): the Padova experience. Clin Biochem. 2021;90:8–14.
   PubMed Web of Science ®Google Scholar
• Long B, Brady WJ, Koyfman A, et al. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38(7):1504–1507.
   PubMed Web of Science ®Google Scholar
• Bonow RO, Fonarow GC, O’Gara PT, et al. Association of Coronavirus Disease 2019 (COVID-19) with Myocardial Injury and Mortality. JAMA Cardiol. 2020;5(7):751–753.
   PubMed Web of Science ®Google Scholar
• Talanas G, Dossi F, Parodi G. Type 2 myocardial infarction in patients with coronavirus disease 2019. J Cardiovasc Med (Hagerstown). 2021;22(7):603–605.
   PubMed Web of Science ®Google Scholar
• Healthcare Cost and Utilization in Project (HCUP). Rockville MD: Agency for Healthcare Research and Quality. (Ed.^(Eds)
   Google Scholar
• StataCorp. Stata Statistical Software: release 17. College Station TX: StataCorp LLC; 2021.
   Google Scholar
• Created with biorender.Com.
   Google Scholar
• Del Prete A, Conway F, Della Rocca DG, et al. COVID-19, Acute Myocardial Injury, and Infarction. Card Electrophysiol Clin. 2022;14(1):29–39. DOI:10.1016/j.ccep.2021.10.004
   PubMedGoogle Scholar
• Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, et al. Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis. Crit Care Med. 2021;49(12):2042–2057. DOI:10.1097/CCM.0000000000005195
   PubMed Web of Science ®Google Scholar
• White K, Kinarivala M, Scott I. Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis. BMJ Open. 2022;12(2):e055755.
   PubMed Web of Science ®Google Scholar
• Putot A, Jeanmichel M, Chague F, et al. Type 2 myocardial infarction: a geriatric population-based model of pathogenesis. Aging Dis. 2020;11(1):108–117.
   PubMed Web of Science ®Google Scholar
• Smilowitz NR, Subramanyam P, Gianos E, et al. Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction. Coron Artery Dis. 2018;29(1):46–52.
   PubMed Web of Science ®Google Scholar
• Chapman AR, Shah ASV, Lee KK, et al. Long- term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation. 2018;137(12):1236–1245. DOI:10.1161/CIRCULATIONAHA.117.031806
   PubMed Web of Science ®Google Scholar
• McCarthy CP, Kolte D, Kennedy KF, et al. Patient characteristics and clinical outcomes of type 1 versus type 2 myocardial infarction. J Am Coll Cardiol. 2021;77(7):848–857.
   PubMed Web of Science ®Google Scholar
• Jin JM, Bai P, He W, et al. Gender Differences in Patients with COVID-19: focus on Severity and Mortality. Front Public Health. 2020;8:152.
   PubMed Web of Science ®Google Scholar
• Vahidy FS, Pan AP, Ahnstedt H, et al. Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: cross-sectional analysis from a diverse US metropolitan area. PLoS ONE. 2021;16(1):e0245556. DOI:10.1371/journal.pone.0245556
   PubMed Web of Science ®Google Scholar
• Stein GY, Herscovici G, Korenfeld R, et al. Type-II myocardial infarction–patient characteristics, management and outcomes. PLoS ONE. 2014;9(1):e84285. DOI:10.1371/journal.pone.0084285
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yang Q, Chi J, et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis. Int J Infect Dis. 2020;99:47–56.
   PubMed Web of Science ®Google Scholar
• Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818. DOI:10.1001/jamacardio.2020.1017
   PubMed Web of Science ®Google Scholar
• Bonaca MP, Wiviott SD, Braunwald E, et al. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38). Circulation. 2012;125(4):577–583. DOI:10.1161/CIRCULATIONAHA.111.041160
   PubMed Web of Science ®Google Scholar
• Gonzalez MA, Eilen DJ, Marzouq RA, et al. The universal classification is an independent predictor of long-term outcomes in acute myocardial infarction. Cardiovasc Revasc Med. 2011;12(1):35–40. DOI:10.1016/j.carrev.2009.11.006
   PubMedGoogle Scholar
• Nestelberger T, Boeddinghaus J, Badertscher P, et al. Effect of definition on incidence and prognosis of type 2 myocardial infarction. J Am Coll Cardiol. 2017;70(13):1558–1568. DOI:10.1016/j.jacc.2017.07.774
   PubMed Web of Science ®Google Scholar
• Farshidfar F, Koleini N, Ardehali H. Cardiovascular complications of COVID-19. JCI Insight. 2021;6(13). DOI:10.1172/jci.insight.148980
   PubMed Web of Science ®Google Scholar
• Wereski R, Kimenai DM, Bularga A, et al. Risk factors for type 1 and type 2 myocardial infarction. Eur Heart J. 2022;43(2):127–135. DOI:10.1093/eurheartj/ehab581
   PubMed Web of Science ®Google Scholar
• Shappell CN, Klompas M, Kanjilal S, et al. Prevalence, clinical characteristics, and outcomes of sepsis caused by severe acute respiratory syndrome coronavirus 2 versus other pathogens in hospitalized patients with COVID-19. Crit Care Explor. 2022;4(5):e0703.
   PubMedGoogle Scholar
• Vakili K, Fathi M, Pezeshgi A, et al. Critical complications of COVID-19: a descriptive meta-analysis study. Rev Cardiovasc Med. 2020;21(3):433–442. DOI:10.31083/j.rcm.2020.03.129
   PubMed Web of Science ®Google Scholar
• McCarthy CP, Januzzi JL Jr., Gaggin HK. Type 2 myocardial infarction　- an evolving entity. Circ J. 2018;82(2):309–315.
   PubMed Web of Science ®Google Scholar